RxDoctor Payments Data

Teddy Shields, DO

Interventional Pain Medicine · Batesville, ARNPI 1972666147

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.4% of the total across 82 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Medtronic at 38.4% of the total. That places this record below the midpoint for interventional pain medicine clinicians in AR, where the typical reported total is $3,706.

$2,398in general payments, 2019–2025

Across 82 payments — averaging $29.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$921
  • Boston Scientific$608
  • AbbVie$253
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$140
  • Stryker$93
  • Si-bone, Inc.$60
  • plus $322 from 14 others

What the payments were for

  • Travel & lodging$1828%
  • Food & beverage$2,21692%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,398 in reported general payments places this provider in the 40th percentile of 29 interventional pain medicine providers in Arkansas.

See all interventional pain medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$346,347
Medicare patients
388
Services billed
4,664

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen2,415$71,695
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen1,706$52,541
Oxycodone Hcl696$11,184
Morphine Sulfate ErMorphine Sulfate104$5,653
Morphine Sulfate141$4,628
Gabapentin279$4,252
Pregabalin226$4,014
Hydromorphone Hcl192$3,511
Naloxone Hcl48$3,166
Lidocaine12$2,594
Tizanidine Hcl203$1,726
Cyclobenzaprine Hcl193$1,499
Acetaminophen-CodeineAcetaminophen With Codeine49$1,428
Celecoxib53$1,418
Tramadol Hcl58$1,254

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Batesville

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →